FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/09/058085 [Registered on: 27/09/2023] Trial Registered Prospectively
Last Modified On: 26/09/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Treatment Of Peripheral Neuropathy In Diabetic Patient 
Scientific Title of Study   AN OPEN LABELLED RCT STUDY ON ASSESSMENT OF COMBINED EFFICACY OF SIRAVYADHA, MADHUTAILIKA BASTI, VATARI RASA AND SHILAJATU RASAYANA IN THE MANAGEMENT OF DIABETIC PERIPHERAL NEUROPATHY (MADHUMEHA UPADRAVA)  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pallavi 
Designation  Kayachikitsa Post Graduate Scholar 
Affiliation  Taranath Govt Ayurvedic Medical College And Hospital Dr Rajakumar Road Bellary  
Address  Taranath Govt Ayurvedic Medical College And Hospital Dr Rajakumar Road Bellary Karnataka India

Bellary
KARNATAKA
583101
India 
Phone  8217453599  
Fax    
Email  pallavidmbidar143@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Fareeda Begum Shaikh 
Designation  Professor Kayachikitsa 
Affiliation  Taranath Govt Ayurvedic Medical College And Hospital Dr Rajakumar Road Bellary  
Address  Taranath Govt Ayurvedic Medical College And Hospital Dr Rajakumar Road Bellary 583101 Karnataka India

Bellary
KARNATAKA
583101
India 
Phone  9886478611  
Fax    
Email  drfareedabegumshaikh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr PALLAVI 
Designation  PG Scholar 
Affiliation  Taranath Govt Ayurvedic Medical College And Hospital Dr Rajakumar Road Bellary  
Address  Taranath Govt Ayurvedic Medical College And Hospital Dr Rajakumar Road Bellary 583101 Karnataka India

Bellary
KARNATAKA
583101
India 
Phone  8217453599  
Fax    
Email  pallavidmbidar143@gmail.com  
 
Source of Monetary or Material Support  
Department Of PG Studies In Kayachikitsa Room No 1 Taranath Govt Ayurvedic Medical College And Hospital Dr Rajakumar Road Bellary 583101 Karnataka India 
 
Primary Sponsor  
Name  Taranath Government Ayurvedic Medical College And Hospital Bellary 
Address  Taranath Govt Ayurvedic Medical College And Hospital Dr Rajakumar Road Bellary 583101 Karnataka India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr pallavi  Taranath Govt Ayurvedic Medical College And Hospital Dr Rajakumar Road Bellary   Department Of Pg Studies In Kayachikitsa Room No 3 Bellary Karnataka.
Bellary
KARNATAKA 
8217453599

pallavidmbidar143@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Taranath Government Medical College Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:G63||Polyneuropathy in diseases classified elsewhere. Ayurveda Condition: Madhumeha Upadrava, (2) ICD-10 Condition:G64||Other disorders of peripheral nervous system. Ayurveda Condition: MADHUMEHAKUSHTHINO ASTHAPANAVYAPADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmProcedure-Madhutailika Basti (Procedure Reference: Ashtanga Hrudaya kalpasthana 4th chapter, Procedure details: 1 Prusruta of Madhu ,1 karsha of Saindhava Lavana Are Added Then 1 Prusruta Murchita Tila Taila ,Ardha Pala Shatapushpa Kalka And 2 Prusruta Erandamula Kwatha Are Added And Mixed Homogeneously And Given To Patient Once In A Day For 7 Days .Then 14 Days Pariharakala ,Again 7 Days Basti Followed By Pariharakala)
(1) Medicine Name: Vatari Rasa, Reference: Rasayogasagara, Route: Oral, Dosage Form: Capsules, Dose: 125(mg), Frequency: qid, Duration: 42 Days
(2) Medicine Name: Shilajatu Rasayana, Reference: Rasasarasangraha, Route: Oral, Dosage Form: Capsules, Dose: 500(mg), Frequency: tds, Duration: 42 Days
2Comparator Arm (Non Ayurveda)-Allopathic Patient Who Will Undergo Through Allopathic Medicine For Diabetic Peripheral Neuropathy
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Male and Female Subjects Of Age Between 25 To 70 Years History Of Diabetes Within 10 Years Diagnosed Cases Of Diabetic Periphearal Neuropathy Who Are Ready To Sign Informed Consent Form Patients Who Are Fit For Basti Siravyadha 
 
ExclusionCriteria 
Details  Neuropathy Due To Other Causes Except Diabetes
Patients Having Diabetes Mellitus 1
Patients Having Diabetic Complication Other Than Neuropathy
Radiculopathies
Also The Subjects Suffering From Severe Systemic Disorders Which Interferes With Course Of Intervention Will Be Excluded 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Relief From Subjective Parameters Daha, Shula, Chimicgimayana, Supti, Dourbalya( Diabetes Peripheral Neuropathy Symptoms)   8 Weeks 3 Days  
 
Secondary Outcome  
Outcome  TimePoints 
Nerve conduction Study Changes  8 Weeks 3 Days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   05/10/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="1"
Days="28" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Summery Of the Study

Diabetic Peripheral Neuropathy is a type of nerve damage that can occcur with diabetes and is most common complication of diabetic mellitus with a lifetime prevalence of about 50-70%.patients of diabtes will lose their sensation in the feet,burning sensation and weakness along with pain.Neuropathy is a coomon complication of diabetes mellitus patient affecting approximately 305.although the invention of insulin and hypogycemia have done a great service for diabetes,yet these patients dont get a proper solution for their neuropathic complications.

The Drugs Used conventionally are mostly for relief in the symptoms and moreover they have certain side effects so it is necessary to explore the possibilities of safer and effective treatment from other sources
The Symptomology correspomding to the clinical presentation of Diabetic Peripheral Neuropathy is scattered in purvaroopa,lakshana,upadrava of Prameha,Vatarakta,Vatavyadhi,Jwara,Pandu.

Madhutailika Basti as it is indicated in Prameha,acts as Deepana,Bramhana,Atyanta Vrushya,Balavarnakara,Upadrava Rahita and Rasayana.

Siravyadha Relieves Suptivata,Padadaha,Padaharsha,Vatashonita. and Whenthere is a pathology of vatarakta along with ruja ,daha,toda,supti asraksravya is indicated.

Vatari Rasa is Vatakapha rogahara,and indicated in Vatarakta,Prameha,Shula,Vatavyadhi.

Shilajatu Rasayana is Sarvapramehahara.

Madhumeha and Diabetic Peripheral Neuropathy are big challenges in medical practice.the research question will more focusing on madhumeha upadrava chikitsa by raktashodhana,basti to control neurovascular integrity and rasarasayana has any positive effect in Diabetic Peripheral Neuropathy on correct evidence based clinical kayachikitsa parameters.hence the presence study entitled

AN OPEN LABELLED RCT STUDY ON ASESSMENT OF COMBINED EFFICACY OF SIRAVYADHA,MADHUTAILIKA BASTI,VATARI RASA AND SHILAJATU RASAYANA IN THE MANAGEMENT OF DIABETIC PERIPHERAL NEUROPATHY(MADHUMEHA UPADRAVA)





OBJECTIVES OF STUDY


1.To Study The Effect Of Siravyadha,Madhutailika Basti,Vatari Rasa,Shilajatu Rasayana In The Managemnt of Diabetic Peripheral Neuropathy.

2.To Asess The Effect Of Modern On Going Intervention In The Management Of Diabetic Peripheral Neuropathy.

3.To Compare The Effect Of Siravyadha,Madhutailika Basti,Vatari Rasa And Shilajatu Rasayana Over Modern On Going Intervention In The Management Of Diabteic Peripheral Neuropathy




STUDY DESIGN

Study Design-Randemised,Standerd Controll,Open And Comparative

Estimated Enrollment-40

Allocation-Randemised

Masking-Open

Study Duration-42 Days

Follow Up After-15 Days




ASSESSMENT CRITERIA


On The Basis Of Subjective And Objective Criteria


Subjective Criteria

1.RUJA(Grade 0=does not complaint of nerve pain,no nerve pain even when asked about it,Grade 1=complaint of nerve pain even when not asked about it,Grade 2=complaint of severe nerve pain and points to the areas of its radiation.the pain does not interfere with sleep.it is aggravated by repeated use of the limb such as manual labour,tailoring etc,Grade 3=says pain is severe,and that it interferes with sleep,the patient keeps the limb in apposition of rest and avaoids its movement

2.HASTAPADA SUPTATA(Grade 0=parasthesia and /decreased tendon reflexs,Grade1 =severe parasthesia and/mild weakness,Grade 2=intolerable parasthesia amd/marked motor loss,Grade 3=paralysis)

3.HASTAPADA DAHA(Grade 0=no burning sensation,Grade 1=occassionally burning sensation,Grade 2=often burning sensation,Grade 3=always burning sensation(disturbing sleep and other activities)

4.Dourbalya(Grade 0=no sign or symptoms,Grade 1=asymptomatic,weakness on examination and testing normally,Grade 2=symptomatic,weakness interfering with function but not interfering ADL,Grade 3=weakness interfering with ADL,Grade 4=life threatening /disabling(paralysis))

5.CHIMICHIMAYANA(Grade 0=none,Grade 1=symptoms from toes to midfoot,not including heel,Grade 2=symptoms from midfoot to ankle,Grade 3=symptoms extend above ankle to knee without upper extremity symptoms,Grade 4=symptoms above knee/concurrent lower and upper extremity symptoms)



Objective Criteria

1.A Standard TORANTO Clinical Scoring System Is Selected For Asessing The Peripheral Neuropathy

2.NCS(Nerve Conduction Study)( Based On Symptom Score,Reflexes,Sensory Test Score,Result)

3.Vitamin B12

4.CRP

5.HBA1C





INVESTIGATION



1.HB%,TC,DC,ESR,CRP,PT INR
2.FBS,PPBS,HBA1C
3.LIPID PROFILE
4.NCS
5.EMG
6.VITAMIN B12





OVERALL ASESSEMENT


Marked/Very Good Improvement--Above 75% Improvement

Moderate/Good improvement--50-75% Improvement

Mild Improvement--25-50% Improvement

Very Mild Improvement--Below 25%

No Improvement At All----0%






 
Close